US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.588
  • -0.037-5.95%
Close Mar 18 16:00 ET
  • 0.578
  • -0.010-1.77%
Post 16:25 ET
50.01MMarket Cap-0.32P/E (TTM)

Century Therapeutics Key Stats

Century Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 475.000K--
--2024/Q4-- / 975.000K--
--2024/Q3791.000K / 550.000K--
--2024/Q2771.000K / 666.670K--
--2024/Q1855.000K / 225.000K--

Unlock Free Earnings Estimates

Century Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 18, 2025

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data